Axios Mobile Assets has signed a letter of intent to supply its proprietary bio-based trackable pallet and software technology to Elba Laboratories for use in logistics operations.
Subscribe to our email newsletter
Axios’ bio-based composite pallet is derived from natural materials and has been engineered to help curtail phytosanitary control issues.
Axios said its pallets contain no decaBDE (Decabromine) and are mold, mildew and insect resistant.
Elba Laboratories is a manufacturer of pharmaceutical and personal care products.
A primary product line for Elba is Medpak, a set of stable formulatory foundations that delivers a host of pharma-based product applications.
Developed specifically for the medical and clinical markets, Medpak products are developed, manufactured, tested, packaged and distributed from Elba’s FDA registered and inspected facility.